Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucarpidase for Routine Use After High Dose Methotrexate in Bone Sarcoma
NCT02022358Phase 2Terminated
- Sponsor
- University College London
- Start
- Jul 2007
- Primary completion
- Jun 2015
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucarpidase in Methotrexate toxicity, sponsored by University College London. Started Jul 2007; status: terminated.
02
Drugs
glucarpidase
03
Conditions
Methotrexate toxicity
Beyond the preview
Go deeper on NCT02022358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02022358.